Dextrose 20 % And 35 % Fresenius 500 ml Solution for infusion.
PDF Leaflet Revision Date: 11 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Hypertonic dextrose-containing solutions for various conditions.
Dosage (summary)
Administer by slow IV infusion; max rate 0.5 g/kg/h.
Special Populations
- Paediatric patients
- Pregnant women
Pregnancy & Breastfeeding
Caution in pregnancy; may cause fetal hyperglycemia and neonatal hypoglycemia.
Key Drug Interactions
- NSAIDs
- Diuretics
- Antiepileptics
Contraindications
- Hypersensitivity
- Anuria
- Intracranial hemorrhage
- Ischaemic stroke
- Delirium tremens
- Glucose-galactose malabsorption
- Hyperglycaemic coma
Common side effects
- Hyperglycaemia
- Hyponatraemia
- Injection site infection
- Fluid imbalance
Counselling Points
- Monitor blood glucose levels
- Avoid rapid infusion
- Inspect solution before use
Serious warnings
- Risk of hyperglycaemia
- Fluid overload
- Electrolyte disturbances
Important Disclaimer
The Dextrose 20 % And 35 % Fresenius 500 ml Solution for infusion. professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
